Hallucinogens Lecture Notes Review

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/24

flashcard set

Earn XP

Description and Tags

Vocabulary flashcards covering the history, classifications, behavioral effects, and neuropharmacological mechanisms of hallucinogenic substances like LSD, psilocybin, and MDMA.

Last updated 2:13 PM on 5/13/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

25 Terms

1
New cards

Hallucinogens

A group of substances that produce changes in thought, perception, and/or mood, with a name derived from the Latin alucinari, meaning “to wander in the mind”.

2
New cards

Psychedelics

A term for hallucinogens meaning “liberation of mind”.

3
New cards

Entheogens

A term for hallucinogens meaning “bringing out the inner god”.

4
New cards

Indolealkylamines

A class of hallucinogens structurally similar to serotonin (5HT5-HT), which includes substances such as LSDLSD, psilocybin, and DMTDMT.

5
New cards

Phenylethylamines

A class of hallucinogens structurally similar to dopamine and norepinephrine, including substances such as mescaline and MDMAMDMA.

6
New cards

LSD (Lysergic acid diethylamide)

A potent indolealkylamine synthesized in 1938 by chemist Albert Hoffman from the ergot fungus; it is typically taken via blotter paper or liquid.

7
New cards

Ergotism

A condition caused by the ergot fungus characterized by a burning sensation in limbs due to vasoconstriction, gangrene, convulsions, and hallucinations.

8
New cards

Delysid

The trade name for LSD25LSD-25 when it was marketed by Sandoz in 1946 for analytical psychotherapy and experimental studies on psychoses.

9
New cards

Project MK-ULTRA

A CIACIA program (1953-1964) that conducted human experiments, often without consent, into mind control and interrogation methods using LSDLSD.

10
New cards

Timothy Leary

A Harvard psychology lecturer in the 1960s who promoted the use of psilocybin and LSDLSD with the slogans “Turn on, tune in, drop out” and “Set and setting”.

11
New cards

Synesthesia

A perceptual phenomenon occurring during the peak of an LSDLSD trip where senses blend, such as “seeing sounds”.

12
New cards

Hallucinogen Persisting Perception Disorder (HPPD)

A condition involving continuous visual disturbances, such as seeing halos or trails, that can persist for weeks or years after drug use.

13
New cards

Psilocybin

The active ingredient in “magic” mushrooms, which is converted to psilocin in the body and produces effects similar to LSDLSD but for a shorter duration (47exthours4-7 ext{ hours}).

14
New cards

Magic Truffles

The subterranean sclerotium of mushrooms like Sclerotium Tampenensis, which contain psilocybin and are often sold in “smart shops”.

15
New cards

Mescaline

A naturally occurring phenylethylamine found in the peyote cactus, used for over 5000 years and currently permitted for religious use in the Native American Church.

16
New cards

Empathogen

A term used to describe the effects of MDMAMDMA, characterized by a sense of euphoria, increased empathy, and feelings of closeness with others.

17
New cards

Alexander Shulgin

The chemist known as the “reinventor of MDMAMDMA” who created more than 300 psychoactive compounds in his home-based lab.

18
New cards

5HT1A5-HT_{1A} receptors

Inhibitory serotonin autoreceptors in the Raphe Nuclei that LSDLSD binds to, though their inhibition is not directly responsible for hallucinogenic effects.

19
New cards

5HT2A5-HT_{2A} receptors

Excitatory serotonin receptors identified as the primary mechanism for hallucinogenesis; agonists of these receptors induce the “head twitch response” in mice.

20
New cards

Head twitch response

A behavioral response in mice (similar to a wet dog shake) that is induced by 5HT2A5-HT_{2A} agonists and is missing in 5HT2A5-HT_{2A} knockout mice.

21
New cards

SERT (Serotonin Transporter)

The primary target of MDMAMDMA, which enters the synaptic terminal via this transporter and reverses its function to release 5HT5-HT into the synaptic cleft.

22
New cards

Oceanic boundlessness

A subjective effect of MDMAMDMA and psilocybin characterized by derealization, depersonalization, positive mood, and an altered sense of time.

23
New cards

Anxious ego-dissolution

A subjective effect involving thought disorder and loss of autonomy associated with fear and anxiety.

24
New cards

Visionary restructuralization

A category of subjective drug effects including auditory and visual illusions, hallucinations, and synesthesia.

25
New cards

Layer V pyramidal neurons

Neurons in the prefrontal cortex where a high density of 5HT2A5-HT_{2A} receptors are located; their preferential activation is a proposed mechanism for hallucinogenesis.